Shares of iRadimed (NASDAQ:IRMD) moved higher by 0.1% in pre-market trading after the company reported Q2 results.

Quarterly Results

Earnings per share were up 180.00% over the past year to $0.14, which beat the estimate of $0.09.

Revenue of $9,810,000 rose by 44.37% from the same period last year, which beat the estimate of $8,460,000.

Outlook

IRADIMED said it sees Q3 adjusted EPS of $0.16-0.17 and sales of $10.3 million-$10.5 million.

How To Listen To The Conference Call

Date: Jul 30, 2021

Time: 11:00 AM

ET Webcast URL: https://edge.media-server.com/mmc/p/5g368eqs

Technicals

Company's 52-week high was at $40.51

52-week low: $20.46

Price action over last quarter: Up 21.76%

Company Profile